cytosine has been researched along with Cytomegaloviral Retinitis in 113 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To describe the complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis." | 9.11 | Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. ( Dunn, JP; Foster, G; Jabs, DA; Kuppermann, BD; Martin, DF; Van Natta, M; Zong, A, 2004) |
| "Although the small number of patients in this study limits definitive interpretation, these data suggest that in the era of highly active antiretroviral therapy, the regimens of the ganciclovir implant plus oral ganciclovir and of intravenous cidofovir are similar for controlling cytomegalovirus retinitis and preventing visual loss but have different side effects." | 9.09 | The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. ( , 2001) |
| "A patient with systemic cytomegalovirus (CMV), including chorioretinitis, received localized and systemic ganciclovir, systemic cidofovir analog, and localized foscarnet." | 7.78 | Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma. ( Chavala, S; Miller, MB; Moss, HB; Say, E, 2012) |
| " Average key pharmacokinetic parameters (Cmax, tmax, lambda z, AUC0-infinity, Vss, CL, CLR, fe, ER) for RDP differed by less than 17% from SDP and were consistent with previously reported SDP data." | 6.71 | Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis. ( Duncan, BA; Ingrosso, A; Mucci, M; Nickens, DJ; Rodríguez, CA; Wolf, DL, 2003) |
| "To describe the complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis." | 5.11 | Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. ( Dunn, JP; Foster, G; Jabs, DA; Kuppermann, BD; Martin, DF; Van Natta, M; Zong, A, 2004) |
| "Although the small number of patients in this study limits definitive interpretation, these data suggest that in the era of highly active antiretroviral therapy, the regimens of the ganciclovir implant plus oral ganciclovir and of intravenous cidofovir are similar for controlling cytomegalovirus retinitis and preventing visual loss but have different side effects." | 5.09 | The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. ( , 2001) |
| "The authors characterize and analyze the incidence of a previously reported mild anterior nongranulomatous uveitis associated with intravitreal injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC), also termed cidofovir (Vistide, Gilead Sciences, Foster City, CA)." | 5.08 | Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. ( Arevalo, JF; Chavez-de la Paz, E; De Clercq, E; Freeman, WR; Kirsch, LS; Munguia, D; Rahhal, FM, 1997) |
| "A patient with systemic cytomegalovirus (CMV), including chorioretinitis, received localized and systemic ganciclovir, systemic cidofovir analog, and localized foscarnet." | 3.78 | Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma. ( Chavala, S; Miller, MB; Moss, HB; Say, E, 2012) |
| "A patient with AIDS and cytomegalovirus (CMV) retinitis received ganciclovir and foscarnet for 20 and 5 months, respectively, with evidence of periodic disease progression." | 3.70 | A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance. ( Chou, S; Drew, WL; Miner, RC, 2000) |
| " Average key pharmacokinetic parameters (Cmax, tmax, lambda z, AUC0-infinity, Vss, CL, CLR, fe, ER) for RDP differed by less than 17% from SDP and were consistent with previously reported SDP data." | 2.71 | Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis. ( Duncan, BA; Ingrosso, A; Mucci, M; Nickens, DJ; Rodríguez, CA; Wolf, DL, 2003) |
| " Dose-dependent asymptomatic proteinuria (39%) and serum creatinine elevation (24%) were the most common adverse events thought to be related to cidofovir." | 2.69 | Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. ( Hardy, WD; Holland, GN; Ives, DV; Jaffe, HS; Johnson, M; Kemper, CA; Kramer, F; Kuppermann, BD; Lalezari, JP; Lewis, RA; McKinley, GF; Nelson, R; Northfelt, DW; Ruby, AE; Simon, GL; Stagg, RJ; Weinberg, DV; Wolitz, RA; Youle, M, 1998) |
| "Eligible patients with acquired immune deficiency syndrome had active CMV retinitis in at least one eye and no evidence of extraocular CMV disease." | 2.68 | Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. ( Arevalo, JF; Chavez de la Paz, E; de Clercq, E; Freeman, WR; Kirsch, LS; Munguia, D, 1995) |
| "Foscarnet, which has similar efficacy to ganciclovir but a different side effect profile, is more difficult to administer and is less well-tolerated." | 2.41 | Therapeutic developments in cytomegalovirus retinitis. ( Hoffman, VF; Skiest, DJ, 2000) |
| " In addition, four treatment modifications were indicated to reduce the incidence of cidofovir-related nephrotoxicity: (a) dose reduction or interruption for changes in renal function; (b) concomitant administration of probenecid; (c) administration of 1 L of normal saline 1 h before infusion of cidofovir; and (d) extension of the dosing interval." | 2.40 | Cidofovir: a new therapy for cytomegalovirus retinitis. ( Lalezari, JP, 1997) |
| " Cidofovir's prolonged intracellular half-life permits dosing once every 2 weeks for maintenance treatment." | 2.40 | Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis. ( Kuppermann, BD; Lalezari, JP, 1997) |
| " Nevertheless, intravenous cidofovir offers a less intrusive administration regimen than intravenous ganciclovir or foscarnet because of its prolonged dosage interval." | 2.40 | Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS. ( Noble, S; Plosker, GL, 1999) |
| "CMV-related retinal detachment is treated surgically." | 2.40 | Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. ( Au Eong, KG; Beatty, S; Charles, SJ, 1999) |
| "A crystalline lipid prodrug, ODE-cCDV, has longer vitreous half-life than that in other ocular tissues due to its solid drug depot formation in vitreous." | 1.37 | Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis. ( Beadle, JR; Cheng, L; Freeman, WR; Hoh, C; Hostetler, KY; Tammewar, A, 2011) |
| "Patients with acquired immunodeficiency syndrome (AIDS) can develop severe uveitis." | 1.37 | Drug-induced uveitis in aids patients: two case reports. ( Bazewicz, M; Caspers, L; Fikri, J; Frippiat, F; Libois, A; Martin, CH; Meunier, A; Willermain, F, 2011) |
| "An exacerbation of the myelitis, retinitis, encephalitis and colitis was observed and a cytomegalovirus infection diagnosed." | 1.31 | CMV complications in common variable immunodeficiency. ( Schmidt, RE; Werwitzke, S; Witte, T, 2000) |
| "The purpose of the study is to evaluate the adverse events and autopsy findings in a series of consecutive 20-microg intravitreous cidofovir injections at a single institution." | 1.30 | Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS). ( Arevalo, JF; Banker, AS; De Clercq, E; Freeman, WR; Mueller, AJ; Rahhal, FM; Rao, NA; Taskintuna, I; Wiley, CA, 1997) |
| "Anterior uveitis was a common complication after intravenous cidofovir therapy." | 1.30 | Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis. ( Akler, ME; Burman, WJ; Johnson, DW; Johnson, SC, 1998) |
| "Eleven AIDS patients receiving HAART with healed CMV retinitis in whom CMV-specific maintenance therapy was discontinued were studied." | 1.30 | Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. ( Freeman, WR; Karavellas, MP; Macdonald, JC; Morse, LS; Reed, JB; Torriani, FJ, 1998) |
| "This iritis was characterized by infiltration of acute inflammatory cells mixed with cytomegalic cells, which was confirmed by CMV-specific immunohistochemical staining." | 1.30 | Cytomegalovirus iritis. ( Avila, CP; Cheng, L; Freeman, WR; Keefe, KS; Macdonald, JC; Rao, NA, 1998) |
| "Fifteen patients with treated cytomegalovirus retinitis, who had immune reconstitution after initiation of highly active retroviral therapy, had anticytomegalovirus maintenance therapy discontinued." | 1.30 | Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy. ( Bolton, SG; Dunn, JP; Jabs, DA; Palestine, AG, 1998) |
| "In the event of ocular hypotony cidofovir should be discontinued in favour of an alternative anti-cytomegaloviral agent." | 1.30 | Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS. ( Ainsworth, J; Bainbridge, JW; Pinching, AJ; Raina, J; Shah, SM, 1999) |
| " Radioactivity in vitreous at 240 h after intravitreal dosing with either drug contained cidofovir, cyclic HPMPC and cidofovir-phosphocholine." | 1.29 | Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits. ( Cundy, KC; Hitchcock, MJ; Lee, WA; Lynch, G; Shaw, JP, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 78 (69.03) | 18.2507 |
| 2000's | 30 (26.55) | 29.6817 |
| 2010's | 5 (4.42) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oshima, K | 1 |
| Kanda, Y | 1 |
| Kako, S | 1 |
| Asano-Mori, Y | 1 |
| Watanabe, T | 1 |
| Motokura, T | 1 |
| Chiba, S | 1 |
| Shiraki, K | 1 |
| Kurokawa, M | 1 |
| Cheng, L | 5 |
| Beadle, JR | 3 |
| Tammewar, A | 1 |
| Hostetler, KY | 3 |
| Hoh, C | 1 |
| Freeman, WR | 17 |
| Bazewicz, M | 1 |
| Fikri, J | 1 |
| Martin, CH | 1 |
| Libois, A | 1 |
| Meunier, A | 1 |
| Frippiat, F | 1 |
| Caspers, L | 1 |
| Willermain, F | 1 |
| Wang, H | 1 |
| Chhablani, J | 1 |
| Hartmann, K | 1 |
| Conner, L | 1 |
| Aldern, KA | 1 |
| Pearson, L | 1 |
| Moss, HB | 1 |
| Chavala, S | 1 |
| Say, E | 1 |
| Miller, MB | 1 |
| Gokulgandhi, MR | 1 |
| Barot, M | 1 |
| Bagui, M | 1 |
| Pal, D | 1 |
| Mitra, AK | 1 |
| Wang, L | 1 |
| Damji, KF | 1 |
| Chialant, D | 1 |
| Hodge, WG | 1 |
| Wolf, DL | 1 |
| Rodríguez, CA | 1 |
| Mucci, M | 2 |
| Ingrosso, A | 1 |
| Duncan, BA | 1 |
| Nickens, DJ | 1 |
| Hackethal, U | 1 |
| Holzapfel, C | 1 |
| Gerding, H | 1 |
| Husstedt, IW | 1 |
| Garneau, M | 1 |
| Bolger, GT | 1 |
| Bousquet, C | 1 |
| Kibler, P | 1 |
| Tremblay, F | 1 |
| Cordingley, MG | 1 |
| Rapp, P | 1 |
| Pilon, F | 1 |
| Chiambaretta, F | 1 |
| Ménérath, JM | 1 |
| Jacomet, C | 1 |
| Song, MK | 1 |
| Azen, SP | 3 |
| Buley, A | 1 |
| Torriani, F | 1 |
| Chaidhawangul, S | 1 |
| Ozerdem, U | 1 |
| Scholz, B | 1 |
| Dunn, JP | 4 |
| Van Natta, M | 1 |
| Foster, G | 1 |
| Kuppermann, BD | 5 |
| Martin, DF | 1 |
| Zong, A | 1 |
| Jabs, DA | 5 |
| Bidanset, DJ | 1 |
| Rybak, RJ | 1 |
| Hartline, CB | 1 |
| Kern, ER | 1 |
| Meyerle, JH | 1 |
| Turiansky, GW | 1 |
| Ortiz, A | 1 |
| Justo, P | 1 |
| Sanz, A | 1 |
| Melero, R | 1 |
| Caramelo, C | 1 |
| Guerrero, MF | 1 |
| Strutz, F | 1 |
| Müller, G | 1 |
| Barat, A | 1 |
| Egido, J | 1 |
| Lu, S | 1 |
| Koh, HJ | 1 |
| Davidson, MC | 1 |
| Kempen, JH | 1 |
| Min, YI | 1 |
| Holland, GN | 4 |
| Friedberg, DN | 1 |
| Dieterich, DT | 1 |
| Nightingale, SL | 1 |
| Kirsch, LS | 3 |
| Arevalo, JF | 6 |
| De Clercq, E | 5 |
| Chavez de la Paz, E | 3 |
| Munguia, D | 5 |
| Garcia, R | 1 |
| Cohen, J | 1 |
| Polis, MA | 1 |
| Masur, H | 1 |
| Cundy, KC | 1 |
| Lynch, G | 1 |
| Shaw, JP | 1 |
| Hitchcock, MJ | 1 |
| Lee, WA | 1 |
| Rahhal, FM | 5 |
| Taskintuna, I | 4 |
| Flaherty, JF | 1 |
| Lea, AP | 1 |
| Bryson, HM | 1 |
| Schwartz, DM | 1 |
| Lalezari, JP | 5 |
| Stagg, RJ | 2 |
| Kramer, F | 2 |
| Ives, DV | 2 |
| Youle, M | 2 |
| Robinson, MR | 2 |
| Drew, WL | 3 |
| Jaffe, HS | 3 |
| Hardy, WD | 2 |
| Chavez-de la Paz, E | 1 |
| Banker, AS | 2 |
| Jacobson, MA | 2 |
| Sadler, M | 1 |
| Morris-Jones, S | 1 |
| Nelson, M | 1 |
| Gazzard, BG | 1 |
| Vittecoq, D | 1 |
| Dumitrescu, L | 1 |
| Beaufils, H | 1 |
| Deray, G | 1 |
| Schliefer, K | 1 |
| Rockstroh, JK | 1 |
| Spengler, U | 1 |
| Sauerbruch, T | 1 |
| Katlama, C | 1 |
| Kravcik, S | 1 |
| Palau, LA | 1 |
| Tufty, GT | 1 |
| Pankey, GA | 1 |
| Vaghjimal, A | 1 |
| Rao, NA | 2 |
| Wiley, CA | 1 |
| Mueller, AJ | 2 |
| Smith, IL | 1 |
| Powell, HC | 1 |
| Ai, E | 1 |
| Spector, SA | 1 |
| Smith, CL | 1 |
| Pau, AK | 1 |
| McKinley, GF | 1 |
| Kemper, CA | 1 |
| Nelson, R | 1 |
| Northfelt, DW | 1 |
| Johnson, M | 1 |
| Lewis, RA | 1 |
| Weinberg, DV | 1 |
| Simon, GL | 2 |
| Wolitz, RA | 1 |
| Ruby, AE | 1 |
| Akler, ME | 1 |
| Johnson, DW | 1 |
| Burman, WJ | 1 |
| Johnson, SC | 1 |
| Schürmann, D | 1 |
| Bergmann, F | 1 |
| Grobusch, MP | 1 |
| Behnsch, M | 1 |
| Liekfeld, A | 1 |
| Macdonald, JC | 3 |
| Torriani, FJ | 3 |
| Morse, LS | 2 |
| Karavellas, MP | 2 |
| Reed, JB | 1 |
| Schleppy, CA | 1 |
| Tritten, JJ | 1 |
| Hammoud, Z | 1 |
| Parenti, DM | 1 |
| Enger, C | 2 |
| Forman, M | 2 |
| Hubbard, L | 1 |
| Garcia, CR | 1 |
| Kersten, A | 2 |
| Althaus, C | 3 |
| Hudde, T | 1 |
| Pascha, G | 1 |
| Schweykart, N | 1 |
| Sundmacher, R | 2 |
| Zabawski, EJ | 1 |
| Cockerell, CJ | 1 |
| Cherrington, JM | 1 |
| Fuller, MD | 1 |
| Lamy, PD | 1 |
| Miner, R | 1 |
| Nuessle, S | 1 |
| Keefe, KS | 1 |
| Avila, CP | 1 |
| Bolton, SG | 1 |
| Palestine, AG | 1 |
| Plummer, DJ | 1 |
| Shufelt, CL | 1 |
| Neau, D | 2 |
| Renaud-Rougier, MB | 1 |
| Viallard, JE | 1 |
| Dutronc, H | 1 |
| Cazorla, C | 1 |
| Ragnaud, JM | 2 |
| Dupon, M | 1 |
| Lacut, JY | 1 |
| Lin, AP | 1 |
| Engstrom, RE | 1 |
| Tseng, AL | 1 |
| Mortimer, CB | 1 |
| Salit, IE | 1 |
| Wilson, S | 1 |
| Stanley, H | 1 |
| Holtzer, C | 1 |
| Cherrington, J | 2 |
| Safrin, S | 2 |
| Skiest, DJ | 2 |
| Canzano, JC | 1 |
| Wendel, RT | 1 |
| Plosker, GL | 1 |
| Noble, S | 1 |
| Ambati, J | 1 |
| Wynne, KB | 1 |
| Angerame, MC | 1 |
| Kersten, AJ | 1 |
| Best, J | 2 |
| Hoy, J | 1 |
| Berenguer, J | 1 |
| Mallolas, J | 1 |
| Au Eong, KG | 1 |
| Beatty, S | 1 |
| Charles, SJ | 1 |
| Bainbridge, JW | 1 |
| Raina, J | 1 |
| Shah, SM | 1 |
| Ainsworth, J | 1 |
| Pinching, AJ | 1 |
| Papastamopoulos, V | 1 |
| Botsis, C | 1 |
| Paparizos, VA | 1 |
| Kyriakis, KP | 1 |
| Zagoraios, Y | 1 |
| Stavrianeas, NG | 1 |
| Witte, T | 1 |
| Werwitzke, S | 1 |
| Schmidt, RE | 1 |
| Theisen, A | 1 |
| Gantke, B | 1 |
| Hoffman, VF | 1 |
| Chou, S | 1 |
| Miner, RC | 1 |
| Seijas, M | 1 |
| de Górgolas Hernández-Mora, M | 1 |
| Nodar, A | 1 |
| Fernández Guerrero, ML | 1 |
| Crippa, F | 1 |
| Corey, L | 1 |
| Chuang, EL | 1 |
| Sale, G | 1 |
| Boeckh, M | 1 |
| Martínez de la Casa, JM | 1 |
| Matilla Rodero, M | 1 |
| Castillo, A | 1 |
| García Feijoó, J | 1 |
| García Sánchez, J | 1 |
| Blanchet, KD | 1 |
| Torres, G | 1 |
| Cheng, B | 1 |
| Feinberg, J | 1 |
| Smart, T | 1 |
| MacDougall, DS | 1 |
| Highleyman, L | 1 |
| Bowers, M | 1 |
| Cadman, J | 1 |
| Rougier, MB | 1 |
| Viallard, JF | 1 |
| Lacut, Y | 1 |
| Korobelnik, JF | 1 |
| Le Rebeller, MJ | 1 |
| Lee, TA | 1 |
| Sullivan, SD | 1 |
| Veenstra, DL | 1 |
| Ramsey, SD | 1 |
| Steger, PJ | 1 |
| Malinverni, R | 1 |
| Pleil, AM | 1 |
| Williamson, T | 1 |
| Seo, SK | 1 |
| Regan, A | 1 |
| Cihlar, T | 1 |
| Lin, DC | 1 |
| Boulad, F | 1 |
| George, D | 1 |
| Prasad, VK | 1 |
| Kiehn, TE | 1 |
| Polsky, B | 1 |
| Soltau, JB | 1 |
| Accorinti, M | 1 |
| Ciapparoni, V | 1 |
| Pirraglia, MP | 1 |
| Pivetti-Pezzi, P | 1 |
| Williams, IG | 1 |
| Maiello, A | 1 |
| Racca, D | 1 |
| Zeme, DA | 1 |
| Quario, M | 1 |
| Sinicco, A | 1 |
| Di Perri, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)[NCT00000143] | Phase 3 | 61 participants (Actual) | Interventional | 1997-05-31 | Completed | ||
| Studies of Ocular Complications of AIDS (SOCA)[NCT00000168] | 2,392 participants (Actual) | Observational | 1998-08-31 | Completed | |||
| Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)[NCT00000142] | Phase 2/Phase 3 | 64 participants (Actual) | Interventional | 1994-04-30 | Completed | ||
| HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol[NCT00000799] | 100 participants | Interventional | Completed | ||||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00000143)
Timeframe: 3 years
| Intervention | participants (Number) |
|---|---|
| Ganciclovir Implant and Oral Ganciclovir | 31 |
| Cidofovir IV (Intravenous) | 30 |
(NCT00000142)
Timeframe: All patients enrolled will be followed until a common study closing date
| Intervention | participants (Number) | ||
|---|---|---|---|
| mortality | progression | va loss of 15 letters | |
| Cidofovir (High Dose) | 3 | 5 | 2 |
| Cidofovir (Low Dose) | 7 | 17 | 6 |
| Treatment Deferral | 6 | 20 | 4 |
22 reviews available for cytosine and Cytomegaloviral Retinitis
| Article | Year |
|---|---|
[Ocular complications of the virostatic drug cidofovir].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 2003 |
Promising new treatments for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants | 1995 |
Cidofovir.
Topics: Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytomegalovirus; Cytomegalovirus Ret | 1996 |
New therapies for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1996 |
Management strategies for patients with cytomegalovirus retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalo | 1997 |
Therapeutic options for resistant cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus | 1997 |
Cidofovir: a new therapy for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Clinical Trials, Phase | 1997 |
Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase II as Top | 1997 |
Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalo | 1997 |
Management of CMV retinitis in HIV infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytome | 1997 |
Local therapy for cytomegalovirus retinitis.
Topics: Administration, Topical; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; C | 1998 |
Cidofovir in the treatment of cytomegalovirus (CMV) retinitis.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Implants; Foscarnet; Ganciclo | 1998 |
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.
Topics: Administration, Cutaneous; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; | 1998 |
Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART).
Topics: Antiviral Agents; Biomarkers; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Diagnosis, Differentia | 1999 |
Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytome | 1999 |
Management of CMV infections in HIV-infected patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1999 |
Cidofovir. Review of current and potential clinical uses.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Clinical Trials as Topi | 1999 |
Cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ga | 1999 |
Therapeutic developments in cytomegalovirus retinitis.
Topics: Adenine; Antibodies, Monoclonal; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; D | 2000 |
[Ocular complications after treatment with intravenous cidofovir for cytomegalovirus retinitis].
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalo | 2001 |
Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 2001 |
Management of CMV disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cyto | 1999 |
13 trials available for cytosine and Cytomegaloviral Retinitis
| Article | Year |
|---|---|
Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 2003 |
Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anesthesia, General; Anesthesia, | 2004 |
Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 1995 |
Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; | 1995 |
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovir | 1997 |
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy | 1997 |
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy | 1997 |
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy | 1997 |
Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Combined Modality Therapy | 1997 |
Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1997 |
Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Creatinine; C | 1998 |
Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 1999 |
Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clin
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 2000 |
The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cyt | 2001 |
SOCA research group stops enrollment. Studies of the Ocular Complications of AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1996 |
Update on treatment of CMV retinitis.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Cidofovir; Cytomegalovirus Retinitis; C | 1995 |
78 other studies available for cytosine and Cytomegaloviral Retinitis
| Article | Year |
|---|---|
Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes.
Topics: Alemtuzumab; Anemia, Refractory, with Excess of Blasts; Antibodies, Monoclonal; Antibodies, Monoclon | 2008 |
Intraocular pharmacokinetics of a crystalline lipid prodrug, octadecyloxyethyl-cyclic-cidofovir, for cytomegalovirus retinitis.
Topics: Animals; Antiviral Agents; Autoradiography; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Eye; Int | 2011 |
Drug-induced uveitis in aids patients: two case reports.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; C | 2011 |
Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.
Topics: Animals; Chromatography, High Pressure Liquid; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; De | 2011 |
Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; DNA, Viral | 2012 |
Transporter-targeted lipid prodrugs of cyclic cidofovir: a potential approach for the treatment of cytomegalovirus retinitis.
Topics: Animals; Antiviral Agents; Biological Transport; Biotinylation; Biotransformation; Cell Line; Cell S | 2012 |
Hypotony after intravenous cidofovir therapy for the treatment of cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Atrophy; Child; Cidofovir; Ciliary Body; Cy | 2002 |
HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique.
Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Models, Animal; E | 2003 |
[Bilateral uveitis with definitive hypotony caused by systemic cidofovir].
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; | 2003 |
Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agent | 2003 |
Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.
Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Disease | 2004 |
Perianal ulcer in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Infections; Cytom | 2004 |
Tubular cell apoptosis and cidofovir-induced acute renal failure.
Topics: Acute Kidney Injury; Adult; Annexin A5; Antiviral Agents; Apoptosis; Caspase 3; Caspases; Cells, Cul | 2005 |
Intraocular properties of hexadecyloxypropyl-cyclic-cidofovir in Guinea pigs.
Topics: Animals; Antiviral Agents; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; Delayed-Action Prepara | 2005 |
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T | 2006 |
From the Food and Drug Administration.
Topics: Advertising; Antiviral Agents; Cidofovir; Commerce; Consumer Advocacy; Cytomegalovirus Retinitis; Cy | 1995 |
AIDS therapy. New hope against blindness.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Blindness; Cidofovir; Clinical Trials as To | 1995 |
Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinit | 1996 |
Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 1996 |
New developments in the treatment of CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1996 |
Current and experimental therapeutic options for cytomegalovirus disease.
Topics: Administration, Oral; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cyto | 1996 |
Cidofovir for AIDS-related retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1996 |
More new drugs for HIV and associated infections.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antiviral Agents; Cido | 1997 |
Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovir | 1997 |
Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; | 1997 |
Fanconi syndrome associated with cidofovir therapy.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Fanconi Syndrome; HIV Seropositivi | 1997 |
Nephrogenic diabetes insipidus in a patient taking cidofovir.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Diabetes Insipidus, Nephrog | 1997 |
Cidofovir for cytomegalovirus retinitis.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Ethics, Medical; Humans; Organopho | 1997 |
Recurrent iritis after intravenous administration of cidofovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cyt | 1997 |
Ophthalmic complications of HIV/AIDS.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1997 |
Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS).
Topics: Adult; AIDS-Related Opportunistic Infections; Anterior Eye Segment; Antiviral Agents; Autopsy; Cidof | 1997 |
[More successful therapy of CMV retinitis in AIDS patients].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosi | 1997 |
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomega | 1998 |
New issues in the management of cytomegalovirus retinitis in AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1998 |
Anterior uveitis and hypotony after intravenous cidofovir for the treatment of cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Coh | 1998 |
Lack of efficacy of cidofovir in treating AIDS-related cytomegalovirus retinitis after long-term treatment with ganciclovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cidofovir; Cytomegalovirus Retinitis; | 1998 |
Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; A | 1998 |
[Fabrication of cidofovir ampules for intravitreal injections for cytomegalovirus retinitis].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Chemistry, Pharmaceutical; Cidofovir; Cytom | 1998 |
Abatement of cutaneous Kaposi's sarcoma associated with cidofovir treatment.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 1998 |
Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug Resistance; Female; Fo | 1998 |
Cytomegalovirus retinitis and viral resistance: 3. Culture results. CMV Retinitis and Viral Resistance Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Baltimore; Blood; Cidofovir; Cytomeg | 1998 |
[Intravitreal injection of cidofovir in cytomegalovirus retinitis].
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 1998 |
[Manufacturing of cidofovir for intravitreal injections in cytomegalovirus retinitis].
Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Drug In | 1998 |
In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome.
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cytosine; Drug Resistance, | 1998 |
Cytomegalovirus iritis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antigens, Viral; Antiviral Agents; | 1998 |
Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T | 1998 |
Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; California; Cidofovir; Cohort Studies; Cyto | 1999 |
Intravenous cidofovir-induced iritis.
Topics: Adult; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Female; Humans; Injections, | 1999 |
Vitrectomy and silicone oil tamponade for cidofovir-associated hypotony with ciliary body detachment.
Topics: AIDS-Related Opportunistic Infections; Cidofovir; Ciliary Body; Cytomegalovirus Retinitis; Cytosine; | 1999 |
Iritis associated with intravenous cidofovir.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis | 1999 |
Surgical repair of cytomegalovirus-related retinal detachment without silicone oil in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cyto | 1999 |
Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte | 1999 |
Cystoid macular edema following immune recovery and treatment with cidofovir for cytomegalovirus retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalo | 1999 |
Intravenous cidofovir for compassionate use in AIDS patients with cytomegalovirus retinitis. Spanish Cidofovir Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cidofovir; Cohort S | 2000 |
Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; CD4 Lymphocyte Count; Cidofovir; Cyto | 1999 |
Lack of reactivation of cytomegalovirus retinitis in an AIDS patient, during and after stopping long-term cidofovir treatment: case report.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomega | 2000 |
Cidofovir: new preparation. Of help in CMV retinitis.
Topics: Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Retinitis; Cytosine; Foscarnet; Ganciclo | 1998 |
CMV complications in common variable immunodeficiency.
Topics: Adult; Antiviral Agents; Azathioprine; B-Lymphocytes; CD4-Positive T-Lymphocytes; CD8-Positive T-Lym | 2000 |
[Stopping secondary prevention in AIDS patients with inactive CMV retinitis treated with HAART (highly active antiretroviral therapy)].
Topics: AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cido | 2000 |
A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Re | 2000 |
[Severe alopecia caused by cidofovir]].
Topics: Adult; AIDS-Related Opportunistic Infections; Alopecia; Antiviral Agents; Cidofovir; Cytomegalovirus | 2000 |
Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation.
Topics: Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytomegalovirus; Cytomegalovirus Retinitis; Cyt | 2001 |
FDA grants marketing clearance of Vistide for the treatment of CMV retinitis.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1996 |
CMV retinitis: a clinical management update.
Topics: AIDS-Related Opportunistic Infections; Algorithms; Antiviral Agents; Cidofovir; Clinical Protocols; | 1996 |
Pharmacia and Upjohn and Gilead sciences receive European recommendation for cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1997 |
Second National Retrovirus conference: a further report.
Topics: Acetamides; Acetophenones; Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Cause of Dea | 1995 |
Advances in the treatment of CMV.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials, Phase I as Topi | 1995 |
Cidofovir approved.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1996 |
Anti-HIV agents at ICAAC.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Cytomegalo | 1996 |
Update on cidofovir for CMV retinitis.
Topics: Administration, Topical; Antiviral Agents; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic | 1997 |
Fomivirsen.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topic; Cytome | 1998 |
Cidofovir.
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytos | 1998 |
A rocky road for nucleotide analogs.
Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Clinical Trials as Topi | 1998 |
[Anterior uveitis and cidofovir].
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Cidofovir; Creatinine; Cytomegal | 2001 |
Cytomegalovirus ventriculoencephalitis in a bone marrow transplant recipient receiving antiviral maintenance: clinical and molecular evidence of drug resistance.
Topics: Antiviral Agents; Bone Marrow Transplantation; Cerebral Ventricles; Child; Cidofovir; Cytomegaloviru | 2001 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: AIDS-Related Opportunistic Infections; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinit | 2001 |
Treatment of severe ocular hypotony in AIDS patients with cytomegalovirus retinitis and cidofovir-associated uveitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agent | 2001 |
A case of flare syndrome.
Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; | 2001 |